Generated July 24, 2026 at 9:37 AM ET
· Covers July 24 trading day
· 10 of 60 ready 8-Ks selected
· AI-assisted overview
Matador Resources agreed to acquire Paloma Permian for $1.275 billion in cash and additional Ridge Runner acreage, while Surgery Partners plans to sell two Idaho Falls hospitals to Intermountain Health for approximately $795 million. C.H. Robinson faces a $604 million advisory verdict in a Texas trucking accident lawsuit, which the company plans to appeal. American Resources dismissed its auditor and stated non-reliance on its 2025 financials after the auditor withdrew its opinion. NewAmsterdam Pharma received a positive CHMP opinion for its obicetrapib products in Europe, and SoundHound AI obtained the final foreign investment clearance for its LivePerson acquisition. Other notable filings include leadership changes at Sidus Space, earnings reports from Tompkins Financial and JAKKS Pacific, and Dyadic International regaining Nasdaq compliance.
leadership
positive
materiality 0.55
July 24, 2026, 9:15 AM ET
Sidus Space appoints Alan Khalili as CFO effective July 27, 2026
- Alan Khalili appointed CFO effective July 27, 2026, succeeding interim CFO John Burke.
- Base salary of $450,000 per year with a 50% annual discretionary bonus.
- Granted 50,000 restricted stock units vesting upon certain conditions.
CHRW
C. H. ROBINSON WORLDWIDE, INC.
litigation
negative
materiality 0.85
July 24, 2026, 6:21 AM ET
C.H. Robinson faces $604M advisory verdict in Texas trucking accident lawsuit
- Dallas County jury issued advisory verdict of $604M in compensatory damages against C.H. Robinson and two other defendants.
- Verdict relates to a trucking accident involving an independent motor carrier; company may be assessed full amount.
- Company disagrees with verdict and plans to appeal if the jury's verdict is entered as final.
NAMS
NewAmsterdam Pharma Co N.V.
regulatory
positive
materiality 0.75
July 24, 2026, 8:03 AM ET
NewAmsterdam Pharma and Menarini receive positive CHMP opinion for obicetrapib products in Europe
- CHMP recommends marketing authorization for Ubeslo (obicetrapib 10 mg) and Evlarco (obicetrapib/ezetimibe FDC) for hypercholesterolemia.
- Recommendation based on Phase 3 BROADWAY, BROOKLYN, and TANDEM trials showing LDL-C reductions up to 40-50% vs placebo.
- European Commission final decision expected in 2H26; if approved, authorization applies across EU plus Iceland, Liechtenstein, Norway.
M&A
positive
materiality 0.70
July 24, 2026, 6:03 AM ET
SoundHound receives final foreign investment clearance for LivePerson acquisition
- Received Bulgarian foreign investment clearance on July 20, 2026, the last required regulatory approval for the LivePerson merger.
- Prior clearances obtained from Italy (June 25), Canada (June 25), Germany (June 29), and UK (July 1).
- All regulatory approval conditions for the merger are now satisfied.
MTDR
Matador Resources Co
M&A
positive
materiality 0.90
July 24, 2026, 7:00 AM ET
Matador to acquire Paloma Permian for $1.275B cash and Ridge Runner acreage; Woodford well test exceeds 2,200 BOE/d
- Paloma Acquisition: $1.275B cash for 16,235 net acres in Eddy/Lea Counties, NM; adds ~11,100 BOE/d (57% oil) and 55 MMBOE proved reserves.
- Ridge Runner Acquisition: adds ~50,000 contiguous net acres in Woodford play; 150+ net operated locations acquired at ~$1.3M per location.
- Rae's Creek Woodford well tested at >2,200 BOE/d (72% oil); 60-day cumulative oil production 20% above average Woodford wells in Texas.
DYAI
DYADIC INTERNATIONAL INC
regulatory
positive
materiality 0.65
July 24, 2026, 8:00 AM ET
Dyadic regains Nasdaq compliance; stock continues trading on Capital Market
- Nasdaq confirmed Dyadic regained compliance with Listing Rules 5550(a)(2) and 5550(b).
- Common stock (DYAI) continues to be listed and traded on the Nasdaq Capital Market.
- CEO Mark Emalfarb stated the company remains focused on executing business strategy and creating shareholder value.
SGRY
Surgery Partners, Inc.
M&A
positive
materiality 0.80
July 24, 2026, 9:01 AM ET
Surgery Partners to sell Idaho Falls hospitals to Intermountain Health for ~$795M
- Transaction values combined facilities at ~$1.15B; Surgery Partners receives ~$795M in total consideration.
- Sale includes Mountain View Hospital and Idaho Falls Community Hospital; physician ownership of MVH unchanged.
- Closing subject to physician approvals, HSR waiting period, and other regulatory consents; expected in coming months.
AREC
American Resources Corp
other material
negative
materiality 0.85
July 24, 2026, 8:00 AM ET
American Resources dismisses auditor; non-reliance on 2025 financials after opinion withdrawal
- Audit Committee dismissed GreenGrowth CPA as auditor on June 30, 2026; no disagreements or reportable events except prior material weaknesses.
- Appointed UHY LLP as new independent auditor on July 11, 2026.
- GreenGrowth withdrew its opinion on Dec 31, 2025 financial statements on July 3, 2026.
TMP
TOMPKINS FINANCIAL CORP
earnings
positive
materiality 0.75
July 24, 2026, 9:02 AM ET
Tompkins Financial Q2 2026 EPS $2.04, up 36% YoY; dividend raised to $0.70
- Diluted EPS $2.04, net income $29.3M, up 36.5% YoY; record third consecutive quarter.
- Net interest margin 3.58%, up 50 bps YoY; loans +6.9% YoY, deposits +4.7% YoY.
- Noninterest income down 41.7% due to sale of insurance subsidiary; noninterest expense down 8.8%.
earnings
positive
materiality 0.75
July 24, 2026, 6:15 AM ET
JAKKS Pacific swings to Q2 profit of $0.49 EPS; sales up 17% to $139.2M
- Net sales $139.2M (+17% YoY); net income $5.9M ($0.49 diluted EPS) vs loss of $2.3M in Q2 2025.
- Adjusted net income $2.9M ($0.25 diluted EPS) vs $0.4M; Adjusted EBITDA $5.4M vs $2.3M.
- Toys/Consumer Products net sales $97.5M (+21%); Costumes $41.7M (+8%); Action Play & Collectibles up 40%.